Table 3.
OR | 95%CI | P value | |
1Model 1 | |||
Age at initiation of ADV (per 5 yr) | 2.90 | 1.16-7.24 | 0.023 |
Treatment duration of ADV (per year) | 2.31 | 1.20-4.45 | 0.013 |
2Model 2 | |||
Age at initiation of ADV (per 5 yr) | 5.01 | 1.07-23.38 | 0.040 |
Treatment duration of ADV (per year) | 3.21 | 1.20-8.57 | 0.020 |
Adjusted for body mass index;
Adjusted for body mass index, gender, the eGFR level at initiation of ADV, and genotyping of ABCC2 -24 C/T. OR, 95%CI, and P value were calculated by logistic regression analysis. ADV: Adefovir dipivoxil; eGFR: Estimated glomerular filtration rate.